NEW YORK, Sept. 14 (GenomeWeb News) - HistoRx, a provider of imaging technology for tissue and tissue microarrays, has raised $1.5 million in a Series A financing round, the company said today.
HistoRx, based in New Haven, Conn., exclusively licenses the imaging technology from YaleUniversity, where it was developed by David Rimm and Robert Camp. The technology allows users to measure protein expression in subcellular compartments automatically. The company also holds an exclusive license to patient cohort databases from Yale's tissue archive containing clinical follow-up information corresponding to different types of human cancer.
HistoRx provides contract services to academic institutions and companies and licenses its technology to selected laboratories.
Navigator Technology Ventures led the investment round, which also included Genentech, Sachem Ventures, and Marnat Investments.